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Abstract
Background: Point prevalence surveys have been used in several studies to provide immediate and easily
comparable information about antibiotic use and showed that about one third of hospitalised children had on
ongoing antimicrobial prescription during their hospital admission. The aim of this study, as part of the Global
Antimicrobial Resistance, Prescribing and Efficacy in Neonates and Children project, is to describe antimicrobial
prescriptions among hospitalised children in four tertiary care hospitals in Italy to show if something has changed
over the years.
Methods: Four tertiary care Italian’s hospitals joined three Point Prevalence Surveys (PPSs) in three different period
of the year. All children under 18 years of age with an ongoing antimicrobial prescription, admitted on the
participating wards at 8 o’clock in the morning of the selecting day were enrolled.
Results: A total of 1412 patients (475 neonates and 937 children) were admitted in the days of three PPSs. Overall,
among the total admitted patients, 565 patients (40%) had an ongoing antimicrobial prescription in the days of the
survey A total of 718 antibiotics were administered in the 485 admitted children and 133 in neonates. The most
common indications for antibiotic therapy in children was Lower respiratory tract infections (244/718, 34%), while in
neonates were prophylaxis for medical problems (35/133, 26.3%), newborn prophylaxis for newborn risk factors (29/
133, 21.8%) and prophylaxis for surgical disease (15/133, 11.3%).
Conclusions: Based on our results, it appears that nothing has changed since the last PPS and that the quality
improved targets, underlyined in previous studies, are always the same. Serial PPSs can be part of AMS strategies
but they are not sufficient alone to produce changes in clinical practice.
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Background
According to the World Health Organization
(WHO)‘s statements, antimicrobial resistance (AMR)
is one of the major contemporary threats to public
health, both for epidemiological and economic rea-
sons [1]. Several studies have demonstrated that AMR
development is related to broad spectrum antimicro-
bial use and that the optimization of AM prescrip-
tions is a key point of antimicrobial stewardship
programs (ASPs) [2]. Repeated Point Prevalence Sur-
veys (PPSs), conducted in several European and non-
European countries, demonstrate high broad spectrum
antibiotic use in hospitals [3–6].
The aim of this study, as part of the Global Antimicro-
bial Resistance, Prescribing and Efficacy in Neonates and
Children (GARPEC) project, was to compare antimicro-
bial prescriptions among hospitalised children in four
tertiary care hospitals in Italy using the same method-
ology from previous pediatric PPS’s, to investigate if pre-
vious PPS studies had led to any change in clinical
prescribing practice.
Methods
The present study is part of the GARPEC, the global
study that followed the European Antibiotic Resist-
ance and Prescribing in European Children project
(ARPEC) [3–6]. Three PPSs were conducted: the first
one from May to June 2016, the second one from
August to September 2016, and the last one from No-
vember to December 2016. Four tertiary care univer-
sity Italian hospitals participated three PPSs. The
methodology and data collection has been described
elsewhere [3–8]. A comparison between the results of
the present study and two other studies conducted in
Italian institutions, with the same methodology, is re-
ported in Table 1 [4, 5].
Statistical analysis
Statistical analysis was performed using SPSS (version
25.0, SPSS Inc., Chicago, IL). Metric data were tested for
normal distribution. Results were expressed as mean
(standard deviation, SD) or median (interquartile range,
IR) as appropriate. Unpaired t test and Mann-Whitney
Table 1 Comparison between the present study and previous PPS studies (4,5)
Ciofi Degli Atti et al. (4) De Luca et al. (5) Present study
Overall
Year June 2007 October–December 2012 February – December 2016
Number of PPSs 1 1 3
Participating hospitals 1 7 4
Percentage of patients with an ongoing AMs**
prescription
43.9% 38.9% 40%
Mean prescription/treated patient 1.4 1.56 1.32
Combination therapy/treated patients 43.8% 41.3% 41.9%
AMs prescribed empirically 51% – 72.6%
AMs use in Neonates
Percentage of neonates receiving AMs -* 17.3% 16.4%
AMs used for prophylaxis – 62.8% 59.4%
AMs used for treatment – 37.2% 40.6%
Most common reason for treatment – Sepsis Sepsis
Top two prescribed AMs – Penicillins Aminoglycosides
Aminoglycosides Ampicillin
AMs use in Children
Percentage of children receiving AMs – 47% 51.8%
AMs used for prophylaxis – 35.5% 21.3%
AMs used for treatment – 64.4% 78.7%
Most common reason for treatment – LRTI LRTI
Top two prescribed AMs Third generation
cephalosporins
Third generation
cephalosporins
Third generation
cephalosporins
Penicilins plus enzyme inhibitor Penicilins plus enzyme inhibitor Penicilins plus enzyme inhibitor
Abbreviations: PPSs: point prevalence surveys; AMs: antimicrobials; LRTI: low respiratory tract infection
* Lacking of analysis disaggregated by age
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tests were used to compare variables between groups.
The χ-square test and Fisher test were performed when
appropriate.
Results
A total of 1412 patients (475 neonates and 937 children)
were admitted on the days of three PPSs were carried
out. Overall 565 patients (40%; 565/1412) received at
least one antibiotic prescription on the days of the sur-
vey, with 51.8% (485/937) and 16.4% (80/475) in chil-
dren and neonates, respectively. Of these, 34.6% (114/
329) in the first PPS, 39.8% (220/552) in the second PPS,
and 47.3% (231/531) in the third PPS; p < 0.005).
Antibiotics prescribed in children
A total of 718 antibiotics (an average of 1.48 antibiotic
prescriptions per children) were administered in children
(aged > 1months) with no significant differences be-
tween three PPSs (p = 0.199). Excluding antibiotics pre-
scribed for prophylaxis, a statistically significantly higher
proportion of antibiotics were prescribed in the second
and in the third PPS (p < 0.001). About 41.9% of children
received a combination of two or more antibiotics. The
two most common indications for antibiotic prescribing
were lower respiratory tract infection (LRTI) (34%) and
prophylaxis for surgical disease and for medical
problems (14.3 and 7.4% respectively). Overall, the most
commonly prescribed antibiotics were the third gener-
ation cephalosporins (26.3%), penicillin with enzyme
inhibitor (18.1%), and aminoglycosides (12.7%). The par-
enteral route of administration was used in 590/718
cases (82.2%). Almost half of patients received antibiotics
reported as community acquired infections (CAI)
(50.8%; 365/718 patients), and only 24.9% (179/718 pa-
tients) as hospital acquired infections (HAI), and 22.1%
(159/718 patients) as prophylaxis. In the cases of antibi-
otics administered for treatment (560/718, 78%), only
27.4% (154/560) of antibiotics were prescribed targeted
treatment with pathogen and antimicrobial susceptibility
test confirmed.
Antibiotics prescribed in neonates
Overall, 16% (80/475) neonates received at least one
antibiotic in the days when PPSs were carried out. Over-
all, 80 neonates received at least one antibiotics in the
days of three PPSs were carried out. Neonates with re-
ported underlying conditions were more likely to receive
antibiotic for treatment compare with those without
underlying condition during the surveys (77.5% vs
22.5%, p < 0.001). Prematurity was the most common re-
ported underlying conditions in our study population
(32.5%; 25/80 patients). Regarding antibiotic prescrip-
tion, a total of 133 antibiotics were administered (an
average of 1.66 antibiotic prescriptions per neonate).
The most commonly prescribed antibiotic, alone or in
combination, was ampicillin or ampicillin and enzyme
inhibitor (27.8%) followed by gentamycin (18.8%).
When the indication for antibiotic use was reported
(127/133), antibiotics were administered for treating
HAIs in 21.3% (27/127), for CAIs in the 15.7% (20/127)
and for prophylaxis in 63% (80/127). The parenteral
route of administration was preferred in 128/133 cases
(96.2%). The most common reasons for antibiotic treat-
ment in neonates were prophylaxis for medical problems
(26.3%), newborn prophylaxis for neonatal risk factors
(21.8%), prophylaxis for surgical disease (11.3%), sepsis
(11.3%), treatment for surgical disease (10.5%) and LRTI
(9%). The two most commonly prescribed antibiotics for
medical prophylaxis were (alone or in combination) gen-
tamycin (9/35, 25.7%) and ampicillin (8/35, 22.8%).
Comparison with previous studies
Two other studies, using the PPSs methodology have
been published in the literature in 2007 and in 2012, re-
spectively (4,5). The percentage of patients with an anti-
biotic prescription, the number of antibiotics/treated
patients, the percentage of antibiotics prescribed empir-
ically and the characteristics of antibiotic use in children
and neonates are reported in Table 1.
Discussion
The present study provides an estimate of antibiotic
use in children and neonates in four tertiary care Ital-
ian hospitals, in three different seasons, using a stan-
dardised PPS methodology. About 40 % of admitted
patients received at least one antibiotic during their
hospital stay; however, when new-borns are excluded,
this percentage increases to more than 50%. These
data are concerningly, very similar to the previous
PPS studies conducted in 2007 and in 2012 in Italian
tertiary care hospitals (Table 1) [3–9]. The three PPSs
reported in the present study, conducted about nine
and seven years after the previous ones, respectively,
did not reveal any reduction in overall AMs use. A
number of specific quality improvement targets, iden-
tified as key points in ASPs, have been developed [1–
3]. The most commonly prescribed remained antibi-
otics were third generation cephalosporins (prescribed
as first choice in LRTIs, skin and soft tissue infections
and joint and bone infections) and penicillin with en-
zyme inhibitor and aminoglycosides. There remained
an extensive use of antibiotics for prophylaxis, both
for medical and surgical reasons, which is not sup-
ported by available guidelines [10]. There was very
high rates of prescribing for prophylaxis in neonates
(60.1%). However, even though the neonatal popula-
tion with risk factors (i.e. prematury) can be consid-
ered particulary vulnerable since invasive procedures
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are often necessary and because of the presence of an
immature immune system, the huge use of antibiotics
for prophylaxis cannot be considered evidence-based
[8, 9, 11].
Conclusions
PPS is an easy method to perform and monitor anti-
biotic use, with the main aim of raising awareness of the
rationale of antibiotic prescriptions in the paediatric
population. However, our study showed that PPSs by
themselves are not sufficient to produce any changes in
the clinical practice if they are not sustained by ASPs.
Based on the present study, it appears that nothing has
changed since the last PPSs [4, 5] and that the quality
improvement targets, underlined in previous studies, are
always the same. More attention should also be focused
on whether this has been noted in other studies. It is un-
clear why there has been limited evidence of improve-
ment in the quality of prescribing. There is very little
published evidence of the optimal design of stewardship
interventions in hospitalised children [12, 13]. The data
presented here suggests that PPS need to be more spe-
cifically combined with simple, cheap and easily imple-
mented stewardship interventions.
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